How patient centricity is enabling the reality of Virtual Trials and mHealth
It’s no secret that one of the greatest challenges facing clinical trials today is patient...
Read More...
Focus:
-
![]()
How CMO/CDMO facilities can gain value with single use containment
That last few years have proven pivotal for contract manufacturing and development organisations (CMOs and...
Read More...
-
![]()
Pharma Technology Focus: buyers clubs in the UK
In this issue: Public attitudes towards mental health drugs, using real-world data in drug approvals,...
Read More...
-
Pharma Technology Focus: Taming big pharma
In this issue: breakthroughs in HIV treatment, understanding drug-resistant TB, the fallout from Teva’s price...
Read More...
-
![Myovant Uterine Fibroid results]()
Myovant reports uterine fibroid combination therapy results
UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase...
Read More...
-
![Mantle cell lymphoma therapies]()
Mantle cell lymphoma: BTK inhibitors have the highest commercial potential
The mantle cell lymphoma (MCL) landscape is diverse, containing nine drugs that are aimed at...
Read More...
-
![biggest pharmaceutical lawsuits]()
The biggest ever pharmaceutical lawsuits
Fraudulent and illegal conduct by pharmaceutical companies poses a great risk to public health and...
Read More...
-
![most expensive drugs in the US]()
Top five most expensive drugs in the US
Despite criticism on high pricing, pharmaceutical companies continue to maintain the high prices of orphan...
Read More...
-
![]()
Pharma Technology Focus: the deep dive for new drugs
In this issue: exploring the potential of the underwater biome in drug development, nationalised drug...
Read More...
-
![Progeria treatment advances]()
Lonafarnib, a hope for progeria treatment
Lonafarnib has emerged as a potential treatment for progeria and progeroid laminopathies, an ultra-rare condition...
Read More...
